After earning a Ph.D. in bioengineering from MIT and an MBA from Harvard Business School, Dr. Zeskind co-founded Immuneering with the goal of improving research and development in the pharmaceutical industry. He bootstrapped the company, recruited a team of world-class computational biologists, and helped established Immuneering as a leader in advanced bioinformatics, with a thriving services business. He also recruited a team of pharmaceutical industry leaders to build a pipeline of drug candidates driven by the company’s Disease Cancelling Technology.
.svg)
